NP

Your Article Summary

See Latest Articles

Denosumab update
Current Opinion in Rheumatology, 06/11/09

Lewiecki EM - Denosumab is a promising therapeutic agent for the management of postmenopausal osteoporosis and rheumatoid arthritis.

Related Articles

See all related articles

Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
The Journal of Urology, 11/16/09    Relevance Score: 87%

A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09    Relevance Score: 83%

Bone health and prostate cancer
Prostate Cancer & Prostatic Diseases, 11/13/09    Relevance Score: 77%

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Valsartan plus hydrochlorothiazide for first-line therapy in hypertension
Expert Review of Cardiovascular Therapy , 12/11/09

Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09

Zoledronic acid: an unending tale for an antiresorptive agent
Expert Opinion in Pharmacotherapy, 12/11/09

 See all of Clinical Pharmacology

Today in Women`s Health...keeping you current

Receive free subspecialty "5-minute updates" via email

Ethical Distinction Between Direct and Indirect Referral for Abortion
The Female Patient, 12/11/09

Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/11/09

Risk Factors for Major Antenatal Depression among Low-Income African American Women
Journal of Women's Health, 12/11/09

 See all of Women`s Health